Relationship between high mobility group protein B1 and infection degree in patients with respiratory failure and pulmonary infection and its prognostic value
ZHANG Xia, MA Hongwei, LI Li, QIU Jingwei
Respiratory Department, the 983rd Hospital of PLA Joint Logistics Support Force, Tianjin 300384, China
Abstract:Objective To investigate the relationship between high mobility group protein B1 (HMGB1) and the degree of infection in patients with respiratory failure (RF) and pulmonary infection (PI) and its prognostic value. Methods A total of 142 patients with RF with PI admitted to the 983rd Hospital of PLA Joint Logistics Support Force from March 2020 to March 2023 were selected. Clinical pulmonary infection score (CPIS) was used to evaluate the infection degree of the patients. The patients were divided into mild infection group (n=79) and severe infection group (n=63), and HMGB1 levels were detected. Pearson correlation coefficient was used to analyze the relationship between HMGB1 and infection degree in RF patients with lung infection. Patients were divided into poor prognosis group and good prognosis group according to their survival condition, and HMGB1 levels of the patients with different prognosis were analyzed. Clinical data of the patients were collected, and multivariate logistic regression model was used to analyze the factors affecting the prognosis of RF patients with PI. The predictive value of HMGB1 in RF patients with PI was analyzed by receiver operating characteristic (ROC) curve. Results Among the 142 patients, 63 cases were severely infected, 79 cases were mildly infected, and the severe infection rate was 44.37%. HMGB1 level and CPIS score in severe infection group were higher than those in mild infection group (P<0.05). The results of Pearson analysis showed that HMGB1 was positively correlated with CPIS score (r=0.586, P<0.05). The mechanical ventilation time, hospital stay and FBG levels in the poor prognosis group were higher than those in the good prognosis group (P<0.05). Logistic regression analysis showed that long mechanical ventilation time and high levels of FBG and HbAlc were risk factors for poor prognosis in RF patients with PI (P<0.05, OR>1). ROC analysis results showed that the sensitivity and specificity of HMGB1 in predicting poor prognosis of RF patients with pulmonary infection were 90.38% and 81.11% respectively, and the area under the curve (AUC) value (95%CI) was 0.804 (0.729-0.866). Conclusions HMGB1 is closely related to the degree of infection in RF patients with lung infection. The high level of HMGB1 is a risk factor for the poor prognosis of RF patients with lung infection, and it is of good value in predicting the poor prognosis of RF patients with lung infection.
张霞, 马红微, 李礼, 邱景伟. 高迁移率族蛋白B1与呼吸衰竭伴肺部感染患者感染程度的关系及预后预测价值[J]. 武警医学, 2024, 35(8): 676-680.
ZHANG Xia, MA Hongwei, LI Li, QIU Jingwei. Relationship between high mobility group protein B1 and infection degree in patients with respiratory failure and pulmonary infection and its prognostic value. Med. J. Chin. Peop. Armed Poli. Forc., 2024, 35(8): 676-680.
Xiong J,Zeng S,Xu H,et al.Aggravated respiratory failure from COVID-19 infection: patient care management from nurses in the intensive care unit[J]. Altern Ther Health Med, 2021,27(S1):228-232.
[2]
Murgia X,Kany A M,Herr C,et al.Micro-rheological properties of lung homogenates correlate with infection severity in a mouse model of Pseudomonas aeruginosa lung infection[J]. Sci Rep, 2020,10(1):16502.
[3]
Chalmers S J,Aksamit T R.New therapies for nontuberculous mycobacterial lung infection[J].Curr Opin Infect Dis, 2022,35(2):176-184.
[4]
Wang H,Wang L,Luo Z, et al. Performance of rapid on-site evaluation of touch imprints of lung tissue biopsies for the diagnosis of pulmonary cryptococcosis in patients without HIV infection[J].Mycoses, 2022,65(6):635-642.
[5]
Samanta S,Patnaik R, Azim A, et al. Incorporating lung ultrasound in clinical pulmonary infection score as an added tool for diagnosing ventilator-associated pneumonia: aprospective observational study from a tertiary care center[J]. Indian J Crit Care Med, 2021,25(3):284-291.
Andersson U,Ottestad W,Tracey K J.Extracellular HMGB1: a therapeutic target in severe pulmonary inflammation including COVID-19[J].Mol Med, 2020,26(1):42.
Ouyang X,Becker E Jr,Bone N B, et al.ZKSCAN3 in severe bacterial lung infection and sepsis-induced immunosuppression[J]. Lab Invest, 2021,101(11):1467-1474.
[13]
Jeyanathan M,Vaseghi-Shanjani M,Afkhami S, et al.Parenteral BCG vaccine induces lung-resident memory macrophages and trained immunity via the gut-lung axis[J]. Nat Immunol, 2022,23(12):1687-1702.
[14]
Al-Kuraishy H M,Al-Gareeb A I,Alkazmi L,et al.High-mobility group box 1 (HMGB1) in COVID-19: extrapolation of dangerous liaisons[J].Inflammopharmacology,2022,30(3):811-820.
Fan Y,Ding Y, Li Y, et al.Investigation of the relationship between community-acquired respiratory distress syndrome toxin and the high-mobility group box protein 1-toll-like receptors-myeloid differentiation factor 88 signaling pathway in Mycoplasma pneumoniae pneumonia[J]. Ital J Pediatr, 2022,48(1):64.
[19]
Zhang X,Su C,Zhao S,et al.Combination therapy of Ulinastatin with thrombomodulin alleviates endotoxin (LPS)-induced liver and kidney injury via inhibiting apoptosis, oxidative stress and HMGB1/TLR4/NF-κB pathway[J]. Bioengineered, 2022,13(2):2951-2970.
[20]
Tanahashi H,Yamaguchi K,Kurose K, et al.Predictive value of serum high-mobility group box 1 levels for checkpoint inhibitor pneumonitis[J]. Respirology, 2023,28(4):380-388.